$0.487
-0.068 (-13.96%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NMRA Prediction & Forecast by Similar Chart Analysis
Alphio's NMRA stock price prediction model matches the current Neumora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.48 (-1.73%). The 1-week path is $0.48 (-0.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neumora Therapeutics Inc Stock?
Neumora Therapeutics Inc is a good buy right now due to its recent price increase of 34.99% yesterday and a 5-day change of 26.16%, indicating strong momentum. The RSI is at 68.963, suggesting it is nearing overbought territory but still has room to grow. However, the company has a significant risk with a net loss of $43.1 million reported for Q2 2026, which highlights ongoing financial challenges. Overall, the potential for recovery and upside in the stock price makes it an attractive buy despite the risks.
NMRA stock price ended at $0.49 on Thursday, after losing -13.96%
Neumora Therapeutics Inc (NMRA) last closed at $0.487, losing -13.96%. These facts feed the 1-day and 1-week NMRA price prediction above.
Forecast Drivers
Neumora Therapeutics Inc (NMRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NMRA, ranked by similarity.
Seasonality analysis for NMRA
Historically the probability of a positive November return for NMRA is 44.19%. February offers the highest probability of a positive month at 60.34%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NMRA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.23 | $2.23 | $2.41 | +358.70% |
| Dec 2026 | $1.48 | $1.81 | $1.86 | +271.51% |
In 2026, Neumora Therapeutics Inc (NMRA) is projected to range from $1.48 to $2.41.
Neumora Therapeutics Inc 2026 monthly forecast
In Nov 2026, Neumora Therapeutics Inc is projected to average $2.23, with a low of $2.23 and high of $2.41.
In Dec 2026, Neumora Therapeutics Inc is projected to average $1.81, with a low of $1.48 and high of $1.86.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.